Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Brief Communication
  • Published:

Transcriptional targeting of dendritic cells for gene therapy using the promoter of the cytoskeletal protein fascin

Abstract

Strong cell-type-specific promoters are basic tools in gene therapy allowing for novel applications and focused strategies by transcriptionally targeting gene expression to selected cells. In immunotherapy, dendritic cells (DC) are of central importance, since they represent the principal inducers of immune responses. Here we describe isolation and use of the promoter of the murine actin-bundling protein fascin to target transcriptionally gene expression to cutaneous DC. Using the reporter gene enhanced green fluorescent protein (EGFP), we demonstrate that the fascin promoter mediates a strong antigen expression that is restricted to mature DC. DNA vaccination with antigen-encoding expression vectors under control of the fascin promoter using a gene gun resulted, consistently, in limited antigen expression by few directly transfected DC. Nevertheless, nearly as many antigen-specific CD8+ T cells directed against the encoded antigens EGFP and β-galactosidase, respectively, were induced as with expression constructs under control of the ubiquitously expressed CMV promoter. This result impressively underlines the pivotal role of directly transfected DC in DNA vaccination. Immunization using the fascin promoter induced markedly lower levels of antigen-specific antibodies following single or repeated immunization. Thus, our DC-targeted DNA vaccination approach induces qualitatively distinct, predominantly cellular immune responses and provides new opportunities for immunotherapy.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Banchereau J, Steinman RM . Dendritic cells and the control of immunity. Nature 1998; 392: 245–252.

    Article  CAS  Google Scholar 

  2. Tüting T, DeLeo AB, Lotze MT, Storkus WJ . Genetically modified bone marrow-derived dendritic cells expressing tumor-associated viral or ‘self’ antigens induce antitumor immunity in vivo. Eur J Immunol 1997; 27: 2702–2707.

    Article  Google Scholar 

  3. Timares L, Takashima A, Johnston SA . Quantitative analysis of the immunopotency of genetically transfected dendritic cells. Proc Natl Acad Sci USA 1998; 95: 13147–13152.

    Article  CAS  Google Scholar 

  4. Kündig TM et al. Fibroblasts as efficient antigen-presenting cells in lymphoid organs. Science 1995; 268: 1343–1347.

    Article  Google Scholar 

  5. Nickoloff BJ, Turka LA . Immunological functions of non-professional antigen-presenting cells: new insights from studies of T-cell interactions with keratinocytes. Immunol Today 1994; 15: 464–469.

    Article  CAS  Google Scholar 

  6. Gaspari AA, Katz SI . Induction of in vivo hyporesponsiveness to contact allergens by hapten-modified Ia+ keratinocytes. J Immunol 1991; 147: 4155–4161.

    CAS  PubMed  Google Scholar 

  7. Ross R et al. The actin-bundling protein fascin is involved in the formation of dendritic processes in maturing epidermal Langerhans cells. J Immunol 1998; 160: 3776–3782.

    CAS  PubMed  Google Scholar 

  8. Ross R et al. Mouse Langerhans cells differentially express an activated T cell-attracting CC chemokine. J Invest Dermatol 1999; 113: 991–998.

    Article  CAS  Google Scholar 

  9. Ross R et al. Expression of the actin-bundling protein fascin in cultured human dendritic cells correlates with dendritic morphology and cell differentiation. J Invest Dermatol 2000; 115: 658–663.

    Article  CAS  Google Scholar 

  10. Jaffe R, DeVaughn D, Langhoff E . Fascin and the differential diagnosis of childhood histiocytic lesions. Pediatr Dev Pathol 1998; 1: 216–221.

    Article  CAS  Google Scholar 

  11. Tang DC, DeVit M, Johnston SA . Genetic immunization is a simple method for eliciting an immune response. Nature 1992; 356: 152–154.

    Article  CAS  Google Scholar 

  12. Condon C et al. DNA-based immunization by in vivo transfection of dendritic cells. Nat Med 1996; 2: 1122–1128.

    Article  CAS  Google Scholar 

  13. Porgador A et al. Predominant role for directly transfected dendritic cells in antigen presentation to CD8+ T cells after gene gun immunization. J Exp Med 1998; 188: 1075–1082.

    Article  CAS  Google Scholar 

  14. Shen Z, Reznikoff G, Dranoff G, Rock KL . Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J Immunol 1997; 158: 2723–2730.

    CAS  Google Scholar 

  15. Xu S et al. Successive generation of antigen-presenting, dendritic cell lines from murine epidermis. J Immunol 1995; 154: 2697–2705.

    CAS  Google Scholar 

  16. Valladeau J et al. Identification of mouse langerin/CD207 in Langerhans cells and some dendritic cells of lymphoid tissues. J Immunol 2002; 168: 782–792.

    Article  CAS  Google Scholar 

  17. Gambotto A et al. Immunogenicity of enhanced green fluorescent protein (EGFP) in BALB/c mice: identification of an H2-Kd-restricted CTL epitope. Gene Therapy 2000; 7: 2036–2040.

    Article  CAS  Google Scholar 

  18. Steitz J, Brück J, Knop J, Tüting T . Adenovirus-transduced dendritic cells stimulate cellular immunity to melanoma via a CD4(+) T cell-dependent mechanism. Gene Therapy 2001; 8: 1255–1263.

    Article  CAS  Google Scholar 

  19. Morita A et al. Development of a Langerhans cell-targeted gene therapy format using a dendritic cell-specific promoter. Gene Therapy 2001; 8: 1729–1737.

    Article  CAS  Google Scholar 

  20. Cho JH, Youn JW, Sung YC . Cross-priming as a predominant mechanism for inducing CD8+ T cell responses in gene gun DNA immunization. J Immunol 2001; 167: 5549–5557.

    Article  CAS  Google Scholar 

  21. Brocker T, Riedinger M, Karjalainen K . Targeted expression of major histocompatibility complex (MHC) class II molecules demonstrates that dendritic cells can induce negative but not positive selection of thymocytes in vivo. J Exp Med 1997; 185: 541–550.

    Article  CAS  Google Scholar 

  22. Jonuleit H et al. Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med 2000; 192: 1213–1222.

    Article  CAS  Google Scholar 

  23. Ochsenbein AF et al. Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction. Nature 2001; 411: 1058–1064.

    Article  CAS  Google Scholar 

  24. Ross R et al. Nonradioactive detection of differentially expressed genes using complex RNA or DNA hybridization probes. Biotechniques 1999; 26: 150–155.

    Article  CAS  Google Scholar 

  25. Sudowe S, Rademaekers A, Kölsch E . Antigen dose-dependent predominance of either direct or sequential switch in IgE antibody responses. Immunology 1997; 91: 464–472.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by the Deutsche Forschungsgemeinschaft, SFB 548 and SFB 432. We thank Dr Albert DeLeo (University of Pittsburgh School of Medicine, Pittsburgh, PA, USA) for providing the EGFP peptide, Dr Kenneth Rock (UMass Medical School, Worcester, MA, USA) for providing the cell line DC2.4, Drs Sem Saeland and Giorgio Trinchieri (both Schering-Plough Laboratory for Immunological Research, Dardilly, France) for providing the anti-langerin antibody 929F3 and Dr Akira Takashima (University of Texas Southwestern Medical Center, Dallas, TX, USA) for providing the cell line XS52. The expert technical assistance of Ms Katrin Krause & Ms Nadine Wiechmann is gratefully acknowledged.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ross, R., Sudowe, S., Beisner, J. et al. Transcriptional targeting of dendritic cells for gene therapy using the promoter of the cytoskeletal protein fascin. Gene Ther 10, 1035–1040 (2003). https://doi.org/10.1038/sj.gt.3301968

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3301968

Keywords

This article is cited by

Search

Quick links